Ayurvedic agent for rectal cancer before standard treatment
Part of Cancer clinical trials.
This trial tests whether an Ayurvedic medicine called Trishul can help shrink rectal cancer tumors when taken before the usual chemotherapy and radiation. It aims to see if combining this natural treatment with standard care improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with rectal cancer that has not spread to other parts of the body.
- Your cancer is at a stage where it can be treated with chemotherapy and radiation before surgery.
- You are generally in good health, with normal blood, kidney, and liver function.
- You have not had prior chemotherapy, radiation, or Ayurvedic cancer treatment.
- You are not pregnant or breastfeeding, and you do not have inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a natural compound called curcumin to standard chemotherapy and radiation before rectal cancer surgery can help shrink the tumor more effectively. It aims to improve outcomes and includes careful monitoring of tumor tissue to understand how the treatment works.
This trial tests a new drug called SHR-1701 combined with standard chemotherapy and radiation for people with locally advanced rectal cancer. The goal is to shrink the tumor before surgery, making it easier to remove completely.
This trial studies whether adding SHR-1701 to standard chemotherapy and long-course radiation can improve treatment for locally advanced rectal cancer that can be removed by surgery. It’s mainly for people who have not had prior rectal cancer treatment and who fit several health and cancer-spread requirements.
This trial studies whether adding TAS-102 (a chemotherapy medicine) to radiation given before treatment improves outcomes for certain locally advanced rectal cancers. It may help by trying to shrink the tumor before the next steps of care.
This trial tests whether giving chemotherapy and an immunotherapy drug before surgery can help shrink rectal cancer tumors and improve outcomes. It is for patients whose tumors are not caused by a specific genetic mismatch repair problem.
This trial tests a combination of short-course radiation, internal radiation (brachytherapy), and several drugs to shrink rectal cancer before surgery. The goal is to improve outcomes and potentially avoid more extensive surgery.
Hear when a new Efficacy of Trishul trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.